Effect of GP IIb/IIIa inhibitor duration on the clinical prognosis of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction with no-/slow-reflow phenomenon

Autor: Hu, Xiangming, Wang, Weimian, Ye, Jingguang, Lin, Yan, Yu, Bingyan, Zhou, Langping, Zhou, Yingling, Dong, Haojian
Zdroj: In Biomedicine & Pharmacotherapy November 2021 143
Databáze: ScienceDirect